IRF8 and B-cell non-Hodgkin lymphoma: In agreement with the mouse B cell lymphoma models, IRF8-mutant DLBCLs displayed significantly diminished signatures of NK cell infiltrate as well as selected CD4 subpopulations, including TH1, but not TH2 (Fig. 7A).